tiprankstipranks
Advertisement
Advertisement

AGEN Stock Latest News

Agenus Extends Debt Maturities and Warrant Expirations
Company AnnouncementsAgenus Extends Debt Maturities and Warrant Expirations
3d ago
8K
AGEN
Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI
PremiumThe Fly
Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI
4d ago
AGEN
Agenus announces three-year survival data from Phase 1b BOT+BAL study
PremiumThe Fly
Agenus announces three-year survival data from Phase 1b BOT+BAL study
15d ago
AGEN
Agenus Shareholders Approve Governance, Compensation and Auditors
PremiumCompany Announcements
Agenus Shareholders Approve Governance, Compensation and Auditors
17d ago
8K
AGEN
Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
PremiumCompany Announcements
Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
29d ago
AGEN
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News5 Healthcare Stocks Set to Join the Russell 3000
1M ago
QSI
AGEN
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
Premium
Ratings
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
2M ago
AGEN
Agenus Announces Resignation of Principal Accounting Officer
Premium
Company Announcements
Agenus Announces Resignation of Principal Accounting Officer
2M ago
8K
AGEN
Agenus announces publication of Phase 1b BOT+BAL data
PremiumThe Fly
Agenus announces publication of Phase 1b BOT+BAL data
2M ago
AGEN
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
PremiumRatings
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
2M ago
AGEN
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
PremiumThe Fly
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
2M ago
BW
GM
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
PremiumThe Fly
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
2M ago
AGEN
Agenus provides 2026 strategic priorities
PremiumThe FlyAgenus provides 2026 strategic priorities
2M ago
AGEN
Agenus announces conclusion of SEC investigation with no enforcement action
Premium
The Fly
Agenus announces conclusion of SEC investigation with no enforcement action
2M ago
AGEN
AGEN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AGEN Earnings this Week: How Will it Perform?
2M ago
AGEN
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
PremiumThe Fly
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
3M ago
AGEN
Agenus reports Phase 2 results from BOT and BAL with agenT-797
PremiumThe Fly
Agenus reports Phase 2 results from BOT and BAL with agenT-797
3M ago
AGEN
Agenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
PremiumThe Fly
Agenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
3M ago
AGEN
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
PremiumRatings
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
3M ago
AGEN
Agenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
PremiumCompany AnnouncementsAgenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
3M ago
AGEN
Agenus Securities Class Action Dismissed, Legal Risks Ease
Premium
Company Announcements
Agenus Securities Class Action Dismissed, Legal Risks Ease
4M ago
8K
AGEN
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
Premium
Ratings
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
4M ago
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >